Inhibitory effects of high-dose methylprednisolone on bacterial translocation from gut and endotoxin release following acute spinal cord injury-induced paraplegia in rats

Neural Regeneration Research

Volumn 5, Issue 6, 2010, Pages 456-460

  Cao, Kai ^a   Huang, Lu ^b   Liu, Jianwei ^c   An, Hong ^d   Shu, Yong ^a   Han, Zhimin ^a  

^a NANCHANG UNIVERSITY   (China)

^b Jiangxi Maternal and Child Health Hospital   (China)

^c The Third People's Hospital of Zigong City   (China)

^d CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Bacterial translocation; Endotoxemia; Methylprednisolone; Spinal cord injury

Indexed keywords

ENDOTOXIN; METHYLPREDNISOLONE; PLACEBO;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS; BACILLUS COLI; BACTERIAL GROWTH; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ENDOTOXEMIA; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HISTOPATHOLOGY; INTESTINE; INTESTINE FLORA; LOCOMOTION; MALE; NONHUMAN; PARAPLEGIA; PROTEUS VULGARIS; RAT; SPINAL CORD INJURY; TOXIN SYNTHESIS; WISTAR RAT;

EID: 77955183018     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2010.06.009     Document Type: Article

References (14)

1. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322:1405-1411.
2. Bracken MB, Shepard MJ, Collins WF Jr, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg. 1992;76:23-31.
3. Camilleri M, Bharucha AE. Gastrointestinal dysfunction in neurologic disease. Semin Neurol. 1996;16:203-215.
4. Husebye E. Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med. 1995;237:419-427.
5. Antequera R, Bretaña A, Cirac A, et al. Disruption of the intestinal barrier and bacterial translocation in an experimental model of intestinal obstruction. Acta Cient Venez. 2000;l51:18-26.
6. Berthoud HR. The vagus nerve, food intake and obesity. Regul Pept. 2008;149(1-3):15-25.
7. Liu J, An H, Jiang D, et al. Study of bacterial translocation from gut after paraplegia caused by spinal cord injury in rats. Spine. 2004; 29:164-169.
8. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
9. Wrathall JR, Pettegrew RK, Harvey F. Spinal cord contusion in the rat: production of graded, reproducible, injury groups. Exp Neurol. 1985;88:108-122.
10. Cho SR, Kim YR, Kang HS, et al. Functional recovery after the transplantation of neurally differentiated mesenchymal stem cells derived from bone marrow in a rat model of spinal cord injury. Cell Transplant. (in press).
11. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12:1-21.
12. Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol. 1996;139(2): 244-256.
13. Basso DM, Beattie MS, Bresnahan JC. Descending systems contributing to locomotor recovery after mild or moderate spinal cord injury in rats: experimental evidence and a review of literature. Restor Neurol Neurosci. 2002;20(5):189-218.
14. Brandenburg K, Howe J, Gutsman T, et al. The expression of endotoxic activity in the Limulus test as compared with cytokine production in immune cells. Curr Med Chem. 2009;16(21): 2653-2660.